BillionToOne

United States
New Lisbon, Wisconsin, United States, 94025

Company profile

BillionToOne company profile

BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to make pre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries. BillionToOne was founded in 2016 and is headquartered in Menlo Park, California.

Business identity

Contact email
[email protected]
Phone number
+1 650-460-2551
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$10M-$100M
Founded
2016-01-01, Year

Headquarters

Postal code
94025
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
8
Total equity funding
$390.9M
Last funding
Series D / $130M / 2024-06-21
Last equity funding
Series D / $130M
Investors
32
Lead investors
6
Founders
3
Articles
159
Exited on
2025-11-06

Founders and investors

Founders

David TsaoOguzhan AtaySukrit Silas

Lead investors

Adams Street PartnersBridge Banke2vcHummingbird VenturesNeotribe VenturesPremji Invest

Investors

500 GlobalAdams Street Partnerse2vcNorwestY Combinator